Cheng Liu

Cheng Liu

Company: Eureka Therapeutics

Job title: President & CEO


Harnessing Gamma Delta TCR Signaling & Alpha Beta T Cell Biology to Balance Cytotoxicity, Target Recognition & Exhaustion 1:30 pm

Contrasting the clinical profile of gamma delta T vs. alpha beta T cells in the clinic Outlining the clinical mechanism of action of gamma delta TCR signaling and activation, and the impact on cell exhaustion and persistence Understanding the importance of TCR specificity and the balance of direction vs. exhaustion Gauging the signal strength required…Read more

day: Day 2 pm track b

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.